Breakthrough in Lp(a) for Cardiovascular Health

Now, there is global momentum for greater Lp(a) awareness and testing. The Brussels International Declaration on Lp(a) Testing and Management urges governments, health systems, and global institutions to “align with and strengthen international CVD prevention strategies across the globe.”  

Key Asks 

• Lp(a) in Cardiovascular Health Plans: Integrate elevated Lp(a) Testing and Management into Global, European and National Cardiovascular Health Plans 

• Investment, workable policy and programmes: Ensure appropriate investment, policy and programmes in Lp(a) Testing and Management based on the recent study demonstrating the significant overall cost saving to health systems across the globe 

• Political Leadership and Commitment: Advocate for political commitment to mandate systematic Lp(a) testing at least once during a person’s lifetime, ideally at an early age, with full reimbursement 

• Global Cardiovascular Risk Assessment: Ensure testing is undertaken in the context of global cardiovascular risk assessment, and to develop personalised cardiovascular health roadmaps as needed, without fear of discrimination 

• Raising Awareness: Drive investment in public and healthcare professional education to increase awareness of Lp(a) and its impact on cardiovascular health. 

Many stakeholders, including patient organizations, clinicians and the public are encouraged to endorse the declaration. 

By raising awareness prioritizing the five points in the declaration, patients will have greater access to testing and treatment, leading to better outcomes.